"Regulatory Readiness Is Built Early" And Other Lessons For CGT Developers

Advanced therapy developers face intense pressure in early clinical phases to generate data quickly, often pushing supply chain planning to the background. However, choices made early regarding logistics, cryopreservation, site selection, and temperature monitoring directly shape long-term regulatory compliance and program viability. Treating supply chain architecture as a core pillar of clinical trial design—rather than a late-stage operational checklist—prevents severe delays during pivotal stages.

Proactively mapping workflows, standardizing material handling, and addressing complex cross-border customs requirements during early development mitigates downstream bottlenecks. By establishing strong operational and regulatory alignment from the start, clinical teams safeguard therapy integrity, maintain program momentum, and streamline regulatory review pathways. Aligning clinical goals with strategic logistics planning creates a predictable foundation for eventual commercial success. Access the full resource to gain actionable strategies for building a resilient supply chain framework.